enGene Holdings Inc.
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENGN and other ETFs, options, and stocks.About ENGN
enGene Holdings, Inc. is a clinical-stage biotechnology company, which engages in developing gene therapies. It is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.
CEORonald Harold Wilfred Cooper
CEORonald Harold Wilfred Cooper
Employees57
Employees57
HeadquartersSaint-Laurent, Québec
HeadquartersSaint-Laurent, Québec
Founded2023
Founded2023
Employees57
Employees57
ENGN Key Statistics
Market cap419.26M
Market cap419.26M
Price-Earnings ratio-4.36
Price-Earnings ratio-4.36
Dividend yield—
Dividend yield—
Average volume363.81K
Average volume363.81K
High today$8.61
High today$8.61
Low today$7.75
Low today$7.75
Open price$7.94
Open price$7.94
Volume104.36K
Volume104.36K
52 Week high$9.85
52 Week high$9.85
52 Week low$2.65
52 Week low$2.65
Analyst ratings
89%
of 9 ratingsBuy
88.9%
Hold
11.1%
Sell
0%
People also own
Based on the portfolios of people who own ENGN. This list is generated using Robinhood data, and it’s not a recommendation.